AZZAD ASSET MANAGEMENT INC /ADV
Position in IONS — Ionis Pharmaceuticals Inc
CIK 1121914
FALLS CHURCH, VA
Position in IONS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$379,323
New position
Shares Held
4,784
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#322
of 510 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $5,807,017 across 7 Biotechnology names. IONS ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,630 | $1,393,768 | |
| 2 | INCY |
Incyte Corp
|
9,067 | $1,027,835 | |
| 3 | TECH |
BIO-TECHNE Corp
|
14,008 | $989,665 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
12,424 | $972,426 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
984 | $613,563 | |
| 6 | EXEL |
Exelixis, Inc.
|
7,911 | $430,437 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
This page
|
4,784 | $379,323 |
All Filings in IONS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $379,323 | 4,784 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||